Uhmontpellier
Montpellier, 34295, France
NCT Number: NCT04647539
Rationale: Beside Candida and Aspergillus, emerging invasive fungal infections (EIFIs) are increasing in intensive care setting and are associated with high morbidity and mortality. However, data are scarce, particularly in ICU settings and for EIFIs other than mucormycosis.
Objectives: to describe epidemiological trends and clinical features of EIFIs in intensive care units (ICU) and to assess their outcome.
Methods: All records of adult patients diagnosed with an EIFI in a medical ICU between 2006 and 2019 were analyzed retrospectively. In-ICU mortality was assessed, then factors associated with mortality were identified. Survival at day-90 was calculated by the Kaplan-Meier method.
Looking for future studies?
Notify Me18 year–99 year
All sexes
Observational
Montpellier, 34295, France
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: at ICU admission
mortality
Time frame: at ICU admission
Mucormycosis
University Hospital, Montpellier
Other
Emerging Invasive Fungal Infections in Critically Ill Patients: Epidemiological Trends, Clinical Features and Outcomes
Acronym: EIFI
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07080359
Aspergillosis, Bacterial Infections and Mycoses
View Trial DetailsNCT02154178
Bacterial Infections and Mycoses, Critical Illness
Lille, Nord, France
View Trial DetailsNCT04368559
Aspergillus, Bacterial Infections and Mycoses
Birmingham, Alabama, United States
View Trial DetailsNCT05202366
Bacterial Infections and Mycoses, Dermatomycoses
Fort Worth, Texas, United States
View Trial Details